Photobiomodulation Therapy on Brain: Pioneering an Innovative Approach to Revolutionize Cognitive Dynamics
Cells · 03.06.2024 · 13 (11) · 966
DOI: 10.3390/cells13110966 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 03.06.2024. Verfasst von Tahsin Nairuz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Keimyung University, Daegu 42601, Republic of Korea. Hauptthemen laut MEDLINE: Low-Level Light Therapy, Brain, Cognition. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Digital Innovation Hub project supervised by the Daegu Digital Innovation Promotion Agency (DIP) grant funded by the Korea government (MSIT and Daegu Metropoli…, Basic Research Program through the National Research Foundation of Korea, Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI).
Abstract (Originalsprache)
Photobiomodulation (PBM) therapy on the brain employs red to near-infrared (NIR) light to treat various neurological and psychological disorders. The mechanism involves the activation of cytochrome c oxidase in the mitochondrial respiratory chain, thereby enhancing ATP synthesis. Additionally, light absorption by ion channels triggers the release of calcium ions, instigating the activation of transcription factors and subsequent gene expression. This cascade of events not only augments neuronal metabolic capacity but also orchestrates anti-oxidant, anti-inflammatory, and anti-apoptotic responses, fostering neurogenesis and synaptogenesis. It shows promise for treating conditions like dementia, stroke, brain trauma, Parkinson’s disease, and depression, even enhancing cognitive functions in healthy individuals and eliciting growing interest within the medical community. However, delivering sufficient light to the brain through transcranial approaches poses a significant challenge due to its limited penetration into tissue, prompting an exploration of alternative delivery methods such as intracranial and intranasal approaches. This comprehensive review aims to explore the mechanisms through which PBM exerts its effects on the brain and provide a summary of notable preclinical investigations and clinical trials conducted on various brain disorders, highlighting PBM’s potential as a therapeutic modality capable of effectively impeding disease progression within the organism—a task often elusive with conventional pharmacological interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Keimyung University, Daegu 42601, Republic of Korea.
ORCID-Profile: Tahsin Nairuz, Jong-Ha Lee
Förderung
- Digital Innovation Hub project supervised by the Daegu Digital Innovation Promotion Agency (DIP) grant funded by the Korea government (MSIT and Daegu Metropoli…
- Basic Research Program through the National Research Foundation of Korea
- Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)
- Korea Medical Device Development Fund grant funded by the Korea government
- National Research Foundation of Korea
- Korea Health Industry Development Institute (KHIDI)
- Korea government
Zitieren
APA
Nairuz, T., Sangwoo-Cho, & Lee, J. H. (2024). Photobiomodulation Therapy on Brain: Pioneering an Innovative Approach to Revolutionize Cognitive Dynamics. Cells, 13(11), 966. https://doi.org/10.3390/cells13110966
Vancouver
Nairuz T, Sangwoo-Cho, Lee JH. Photobiomodulation Therapy on Brain: Pioneering an Innovative Approach to Revolutionize Cognitive Dynamics. Cells. 2024;13(11):966. doi:10.3390/cells13110966
BibTeX
@article{Nairuz2024,
author = {Nairuz, Tahsin and Sangwoo-Cho and Lee, Jong-Ha},
title = {Photobiomodulation Therapy on Brain: Pioneering an Innovative Approach to Revolutionize Cognitive Dynamics},
journal = {Cells},
year = {2024},
volume = {13},
number = {11},
pages = {966},
doi = {10.3390/cells13110966}
}
EUVIMED